Bioengineered coagulation factor VIII enables long-term correction of murine hemophilia A following liver-directed adeno-associated viral vector delivery.

Bioengineered coagulation factor VIII enables long-term correction of murine hemophilia A following liver-directed adeno-associated viral vector delivery.
复制标题

DOI:
10.1038/mtm.2014.36
复制
发表时间:
2014
期刊:
Molecular therapy. Methods & clinical development
影响因子:
--
通讯作者:
--
中科院分区:
其他
文献类型:
--
作者:

文献摘要

参考文献

被引文献

相似文献

Clinical data support the feasibility and safety of adeno-associated viral (AAV) vectors in gene therapy applications. Despite several clinical trials of AAV-based gene transfer for hemophilia B, a unique set of obstacles impede the development of a similar approach for hemophilia A. These include (i) the size of the factor VIII (fVIII) transgene, (ii) humoral immune responses to fVIII, (iii) inefficient biosynthesis of human fVIII, and (iv) AAV vector immunity. Through bioengineering approaches, a novel fVIII molecule, designated ET3, was developed and shown to improve biosynthetic efficiency 10- to 100-fold. In this study, the utility of ET3 was assessed in the context of liver-directed, AAV-mediated gene transfer into hemophilia A mice. Due to the large size of the expression cassette, AAV-ET3 genomes packaged into viral particles as partial genome fragments. Despite this potential limitation, a single peripheral vein administration of AAV-ET3 into immune-competent hemophilia A mice resulted in correction of the fVIII deficiency at lower vector doses than previously reported for similarly oversized AAV-fVIII vectors. Therefore, ET3 appears to improve vector potency and mitigate at least one of the critical barriers to AAV-based clinical gene therapy for hemophilia A.
DOI: 10.1111/j.1365-2141.1984.tb06111.x
发表时间: 1984-01-01
影响因子: 6.5
作者:
CIAVARELLA, N;ANTONCECCHI, S;RANIERI, P
通讯作者: RANIERI, P
DOI: 10.1083/jcb.105.6.2665
发表时间: 1987-12-01
影响因子: 7.8
作者:
DORNER, AJ;BOLE, DG;KAUFMAN, RJ
通讯作者: KAUFMAN, RJ
DOI: 10.1182/blood-2012-10-462200
发表时间: 2013-04-25
期刊: BLOOD
影响因子: 20.3
作者:
McIntosh, Jenny;Lenting, Peter J.;Nathwani, Amit C.
通讯作者: Nathwani, Amit C.
DOI: 10.1038/mt.2009.35
发表时间: 2009-07-01
期刊: MOLECULAR THERAPY
影响因子: 12.4
作者:
Doering, Christopher B.;Denning, Gabriela;Spencer, H. Trent
通讯作者: Spencer, H. Trent
DOI: 10.1007/978-1-61779-370-7_18
发表时间: 2011-01-01
期刊: ADENO-ASSOCIATED VIRUS: METHODS AND PROTOCOLS
影响因子: --
作者:
High, Katherine A.;Aubourg, Patrick
通讯作者: Aubourg, Patrick